Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Category M sees 10% price increase

According to Tariff Watch, produced by the Medicines Management Network - North West the prices of Category M drugs were increased by 10% in April.

The author of Tariff Watch, Andrew Martin from Bury PCT, estimates that this could mean an additional 2% in expenditure on the entire drug budget if these prices remain unchanged for the year.

Category M was introduced by the Department of Health in April 2005 as part of the Pharmacy Contract. The Pharmaceutical Services Negotiating Committee (PSNC) has produced a summary explaining the key points of the system.

Category M products are available as generics and are quite often the drug of choice within a particular class based upon lower acquisition costs.

Action: Clinicians should ensure that Category M drugs are used wherever possible to offset this potential increase in drugs expenditure. Where possible, the process for setting Prescribing Budgets should take into account changes in Category M price where possible.

Share 'Category M sees 10% price increase' on Email Share 'Category M sees 10% price increase' on Delicious Share 'Category M sees 10% price increase' on Digg Share 'Category M sees 10% price increase' on Facebook Share 'Category M sees 10% price increase' on reddit Share 'Category M sees 10% price increase' on Twitter

atomic-wealth

No Comments to “Category M sees 10% price increase”

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.

atomic-wealth
fond-illness
summer